The independent source for health policy research, polling, and news.
4,681-4,700 of 113,059 results
In a lengthy speech, President Joe Biden touted his many health care accomplishments during his single term. In perhaps the biggest surprise of the Democratic National Convention, several speakers criticized former President Donald Trump's inaction during the covid pandemic and mentioned a relative who died from the virus.
Today's early morning highlights from the major news organizations.
The new BiVACOR artificial heart uses a magnetic levitating rotor to pump blood, eliminating wear issues seen with more traditional artificial heart pumps. The nation, meanwhile, is facing a shortage of donated blood—particularly the useful Type O variant.
Editorial writers discuss these current issues.
Ten Republican-led states had challenged Title IX expansion, and the Supreme Court declined to lift lower court bans on enforcing the anti-discrimination rules for students. Meanwhile, a new parental-consent law concerning medical treatments is said to worry school nurses in Tennessee.
A new report from Wake Forest University found a poor working environment for nurses and dangerous situations for patients were caused by HCA's management style at Mission Hospital in Asheville, North Carolina. Meanwhile, in Massachusetts, 6 Steward Health hospitals now have new owners.
The disease is spread by small flies and some types of mosquitoes and can cause sudden fever, severe headaches, and chills. Meanwhile, the first human case of mosquito-borne Eastern equine encephalitis since 2020 in Massachusetts was reported.
The shots, from Moderna and Pfizer/BioNTech, will target the KP.2 strain of the virus. There's no word on whether the FDA will address Novavax's shot targeting JN.1. Meanwhile, the CDC says KP.3.1.1 is now the dominant strain in the U.S. (Feeling lost? Both KP.2 and KP.3 are part of the FLiRT variants, which are subvariants of JN.1, which is a subvariant of omicron.)
The agreement would settle a lawsuit by a whistleblower who alleges that the health insurer overcharged the federal Medicare program while administering prescription drug benefits. Humana did not admit wrongdoing in the agreement.
The test, which is called First To Know and will cost $29.98, uses a drop of blood and offers results in about 15 minutes. Other news is on pap smears, salpingectomies, and uterus transplants.
The Democratic National Convention kicks off in Chicago today. The docket includes three women who will tell their pregnancy stories. Other speakers are expected to spotlight health issues like drug prices and medical debt.
Today's early morning highlights from the major news organizations.
Editorial writers tackle these public health issues.
Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on AMR, extreme heat, dementia, homelessness, Zyn, and more.
Meanwhile, in Baltimore, a lawsuit against opioid makers and distributors will proceed to trial after a judge denied motions by the companies to dismiss the case. And MIT News reports on an implantable device that could automatically release naloxone in overdose situations.
Ciprofloxacin is recommended for post-exposure prophylaxis against bacterial meningitis, but the New York State Department of Health is asking providers to discontinue using it over fears of rising antibiotic-resistant strains.
Perchlorate is more likely to be found in types of food given to youngsters, a Consumer Reports study found. There is no strict definition of what is considered to be a "dangerous level" of perchlorate, which is found in such items as fireworks, matches, and now french fries and chicken nuggets.
Abortion is legal until fetal viability, but few clinics are left in the state, and there are no surgical abortion clinics at all in Northwest and Southeast Ohio. The lack of access is troublesome for residents, who may have to travel out of state for care. Meanwhile, women in surrounding states where abortion is banned are seeking help in Ohio.
Traumagel, from Cresilon, can be used for life-threatening injuries and could be a vital new tool for EMTs. Separately, the FDA approved a non-small cell lung cancer treatment from AstraZeneca.
An increase in high-dollar treatments and greater demand for prescription drugs are driving up costs for employers, the company says. Meanwhile, supply chain woes in 2023 hampered health providers' ability to provide care to ailing patients.
© 2026 KFF